vTv Therapeutics (VTVT) Price to Book (2015 - 2026)

vTv Therapeutics has disclosed Price to Book across 12 years of filings, most recently posting 5.94 for Q2 2026.

• In Q2 2026, Price to Book fell 85.54% year-over-year to 5.94; the TTM figure through Jun 2026 stood at 5.94 (down 85.54% YoY), while the FY2025 annual figure was 5.23, down 6.19% from the prior year.
• Price to Book came in at 5.94 for Q2 2026 at vTv Therapeutics, up from 5.47 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 41.08 in Q2 2025 to a low of 8.83 in Q2 2022.
• Average Price to Book over 5 years is 2.89, with a median of 3.21 recorded in 2024.
• Year-over-year, Price to Book sank 1540.8% in 2022 and surged 642.47% in 2025.
• Over 5 years, Price to Book stood at 6.45 in 2022, then jumped by 80.78% to 1.24 in 2023, then surged by 549.2% to 5.57 in 2024, then dropped by 6.19% to 5.23 in 2025, then rose by 13.66% to 5.94 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 5.94 in Q2 2026, 5.47 in Q1 2026, and 5.23 in Q4 2025.